Bracebridge Capital LLC’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Bracebridge Capital LLC’s Portfolio IQMDU Stock Details IQMDU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,000	Closed	-$256K	–	97
2022 Q4	$256K	Hold	25,000	–	–	0.02%	68
2022 Q3	$254K	Hold	25,000	–	–	0.04%	86
2022 Q2	$251K	Hold	25,000	–	–	0.04%	88
2022 Q1	$253K	Hold	25,000	–	–	0.02%	91
2021 Q4	$255K	Buy	+25,000	New	+$253K	0.02%	94

Other funds holding IQMDU

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

BHWM

Beaird Harris Wealth Management Dallas, Texas $1.6B AUM 16.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

RCM

Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bracebridge Capital LLC's IQMDU Position: Q1 2023 in Review

Bracebridge Capital LLC sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q1 2023, closing a stake of 25,000 shares — an estimated $256K sold.

Bracebridge Capital LLC first reported a position in IQMDU in Q4 2021 and held it in 5 quarters. The position peaked at $256K in Q4 2022. 6 funds tracked by Wall St. Rank hold IQMDU as of Q1 2023.

Bracebridge Capital LLC reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
Bracebridge Capital LLC sold 25,000 Intelligent Medicine Acquisition Corp. Unit shares in Q1 2023, an estimated $256K.
Bracebridge Capital LLC first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 5 quarters.
Bracebridge Capital LLC's Intelligent Medicine Acquisition Corp. Unit position peaked at $256K in Q4 2022.
6 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q1 2023.

Based on Bracebridge Capital LLC's 13F filing for Q1 2023, filed 12 May 2023.